Mcguire Capital Advisors »

Ptc Therapeutics I shares owned by Mcguire Capital Advisors

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Mcguire Capital Advisors from 13F filings

Historical chart of Mcguire Capital Advisors investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Mcguire Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Mcguire Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $397k 5.2k 75.96

More positions owned by Mcguire Capital Advisors

NVIDIA Corporation (NVDA)
Tidal Trust Ii Yieldmax Nvda (NVDY)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Exxon Mobil Corporation (XOM)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Oneok (OKE)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Caterpillar (CAT)

View all positions for Mcguire Capital Advisors

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
State Street Corporation
Henderson Group
Armistice Capital
Toronto-Dominion Bank
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
Leucadia National Corporation
FMR
Tang Capital Management
Franklin Resources

View all funds holding Ptc Therapeutics I